OXIGENE INC
OXiGENE is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases. The Company's major focus is developing vascular disrupting agents (VDAs) that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.
OXIGENE INC
Industry:
Biotechnology
Address:
South San Francisco, California, United States
Country:
United States
Status:
Active
